Pharmacological characterization of the seven human NOX isoforms and their inhibitors.

Clicks: 405
ID: 3427
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #10 of 74 articles by views in Redox biology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
NADPH oxidases (NOX) are a family of flavoenzymes that catalyze the formation of superoxide anion radical (O) and/or hydrogen peroxide (HO). As major oxidant generators, NOX are associated with oxidative damage in numerous diseases and represent promising drug targets for several pathologies. Various small molecule NOX inhibitors are used in the literature, but their pharmacological characterization is often incomplete in terms of potency, specificity and mode of action.We used cell lines expressing high levels of human NOX isoforms (NOX1-5, DUOX1 and 2) to detect NOX-derived O or HO using a variety of specific probes. NOX inhibitory activity of diphenylene iodonium (DPI), apocynin, diapocynin, ebselen, GKT136901 and VAS2870 was tested on NOX isoforms in cellular and membrane assays. Additional assays were used to identify potential off target effects, such as antioxidant activity, interference with assays or acute cytotoxicity.Cells expressing active NOX isoforms formed O, except for DUOX1 and 2, and in all cases activation of NOX isoforms was associated with the detection of extracellular HO. Among all molecules tested, DPI elicited dose-dependent inhibition of all isoforms in all assays, however all other molecules tested displayed interesting pharmacological characteristics, but did not meet criteria for bona fide NOX inhibitors.Our findings indicate that experimental results obtained with widely used NOX inhibitors must be carefully interpreted and highlight the challenge of developing reliable pharmacological inhibitors of these key molecular targets.
Reference Key
augsburger2019pharmacologicalredox Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Augsburger, Fiona;Filippova, Aleksandra;Rasti, Delphine;Seredenina, Tamara;Lam, Magdalena;Maghzal, Ghassan;Mahiout, Zahia;Jansen-Dürr, Pidder;Knaus, Ulla G;Doroshow, James;Stocker, Roland;Krause, Karl-Heinz;Jaquet, Vincent;
Journal Redox biology
Year 2019
DOI
S2213-2317(19)30520-8
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.